Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases Article (Web of Science)

International Collaboration

cited authors

  • Su, Shang; Cao, Jingchen; Meng, Xiangqi; Liu, Ruihua; Vander Ark, Alexandra; Woodford, Erica; Zhang, Reian; Stiver, Isabelle; Zhang, Xiaotun; Madaj, Zachary B.; Bowman, Megan J.; Wu, Yingying; Xu, H. Eric; Chen, Bin; Yu, Haiquan; Li, Xiaohong

publication date

  • January 28, 2022


published in



  • Bone microenvironment
  • Enzalutamide resistance
  • PTH1R
  • Prostate cancer
  • TGFBR2

start page

  • 170

end page

  • 178


  • 525